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We compared the Austin Moore hemiarthroplasty versus cemented hemiarthroplasties using a propensity score matched cased
control study. For a consecutive cohort of 450 patients with displaced intracapsular neck of femur fractures, 128 matched cases
in each group were selected based on age, gender, walking status, nursing home residency, delays in surgery, ASA score, and the
Charlson comorbidity score. At a mean follow-up of 16.3 months, we evaluated their outcomes. Significantly more patients with
AMA experienced thigh pain (RR = 3.5, 95% CI: 1.67–7.33, 𝑝 = 0.000), overall complications (RR = 4.47, 95% CI: 1.77–11.3, 𝑝 =
0.000), and implant loosening (RR = 8.42, 95% CI: 2.63–26.95, 𝑝 = 0.000). There were no definite cement related deaths in this
series.There was no significant difference inmortality, walking status, and the number of revisions between the groups.We support
the routine use of cemented hemiarthroplasty instead of the Austin Moore for treating elderlies with displaced intracapsular neck
of femur fractures.
1. Introduction
Intracapsular neck of femur fracture is common in the
elderly and typically managed by hemiarthroplasty when
displaced. The Austin Moore hemiarthroplasty (AMA) was
introduced in the 1950s [1]. It is a monobloc cementless
hemiarthroplasty system with a nonporous coated collared
perforated stem inserted by press fit. Although modern
modular porous coated cementless systems and cemented
systems have continued to evolve, the AMA remains to be in
regular use by developed countries [2].
Despite early reports which suggested that uncemented
monobloc stems were prone to mechanical loosening and
thigh pain [3–5], they remain to be commonly used.
Monobloc stems accounted for nearly one-sixth of the 60000
partial hip replacements for fractures in Australia from
2009 to 2014 [2]. In our region, the AMA remained to
be the most used prostheses until 2010 for three main
reasons. Firstly, small canal diameters in the local population
were common [6], precluding routine usage of the other
economical cemented monobloc stems such as the Thomp-
son prosthesis. Secondly, there was insufficient evidence
to justify routine use of the more costly modern modular
implants [7].Thirdly, surgeons were concerned about cement
related embolic complications and mortalities [8, 9] in frail
elderlies.
More recently an additional high quality randomized
study by Parker et al. [10] favourably compared cemented
monobloc stems against the AMA. It was shown that
cemented implants resulted in better function, less pain,
and less implant related complications with no appar-
ent increase in the risk of cement related complications.
The objective of our study was to reconfirm this by a
propensity score (PS) matched case control study in the
local population after a resultant change in our healthcare
policy.
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2. Methodology
We retrospectively reviewed a consecutive cohort of patients
in a university affiliated tertiary hospital with intracapsular
hip fractures admitted from December 2010 to June 2014
treated by primary hemiarthroplasty. All patients with the
Enhanced ICD-9-CM diagnosis code of 820 (Fracture of
Neck of Femur) and procedure code of 81.52 (partial hip
replacement) were queried and retrieved from the hospital
operative record database.
Patients with pathological fractures were excluded.
450 patients with hemiarthroplasties were obtained. The
cemented group consisted of modular or monobloc or
cemented implants, and the AMA group consisted solely
of uncemented prosthesis. As mandated by the local hip
fracture pathway [11], all procedures were carried out using
the posterolateral approach as described by Moore [1]. All
patients were allowed immediate weight bearing after surgery
and followed a standard in-patient rehabilitation programme.
In the first half of our study period, the AMA was routinely
used in most patients while cemented modular stems were
used routinely in the second half due to a change in healthcare
policy.
PS matching [12] was carried out as an effort to negate
confounding at patient selection which may have occurred
in very active or very frail patients. Except for the date of
surgery, possible confounding variables in affecting decision
making were matched between the two groups.These factors
were age, sex, preinjury walking state, residency in a nursing
home, Charlson comorbidity score [13] (CCS), American
Society of Anaesthesiology (ASA) score, and days of delay in
surgery. SPSS (Version 23, IBM, Armonk, USA), R (Version
3.10,The R Foundation, Vienna, Austria), and theThoemmes
algorithm [14] (version 3.04) were used for propensitymatch-
ing and statistical analysis. The standard nearest-neighbour,
one-to-one technique was used with a caliper value of 0.2
[15]. Between the two groups, all confounding variables were
compared before and after PS matching to ensure that a
standardizedmean difference of 0.25 or less was obtained and
also that none of these baseline variables were significantly
different statistically (Table 1).
The territory wide electronic healthcare database which
covered all public hospitals and 95% of the local popula-
tion was reviewed for each patient. The outcome measures
were compared under three categories. They were mortality,
clinical outcome, and complications. Mortality data was
recovered from the territory wide death registry for all
patients who were analysed. Only patients with clear clinical
documentation of their functional status after rehabilitation
were analysed for clinical outcomes. The three research
assistants responsible for charting of clinical outcomes were
blinded from the type of prosthesis. Four authors assessed
the radiological outcomes and complications and each result
was cross verified between two authors. Only patients with
radiological follow-up of more than 90 days or those with
an earlier known complication were included for radiological
and complication analysis.
The radiological complications were implant loosening,
defined as a continuous radiolucent line of more than 2mm
which surrounded the stem, stem subsidence of more than
5mm, or gross varus or valgus displacement. Other compli-
cations included deep or superficial wound infections, dis-
locations, intraoperative cracks, and postoperative traumatic
and atraumatic periprosthetic fractures. All revision surgeries
were recorded.
The Pearson Chi square test was used for dichotomous
variables with frequent occurrences and the Fisher exact test
was used for variables with small occurrences.The two-tailed
𝑡-test was used for continuous variables. A 𝑝 value of less
than 0.05 was taken as statistically significant. Comparisons
between the two groups before and after PS score matching
were listed in the results of the study. The relative risk (RR)
with 95% confidence intervals and the number needed to
treat (NNT) was calculated for significant outcomes with
AMA being the group exposed to risk.
3. Results
From the database query, there were 146 cemented implants
including 114 collarless polished tapered modular cemented
stems with a bipolar or monopolar head and 32 cemented
monobloc collared hemiarthroplasties.There were 304 unce-
mented AMAs in the other group. After propensity score
matching, there were 128 patients with a cemented stem
and 128 matched patients with an AMA. The mean interval
for latest clinical follow-up was 20.7 months and the mean
interval for latest X-ray was 16.5 months.
In the matched cemented and AMA group, respectively,
the mean age was 80.7 and 81.0. There were no differences
between the two groups in terms of gender, premorbid
walking ability, residence in a nursing home, average delay
from admission to surgery, CCS, and ASA scores. For above
factors the maximum standardized mean difference was
0.093, indicating two very closely matched groups.
The mean duration of surgery was 67.7 minutes for a
cemented hemiarthroplasty and 56.1 minutes for an AMA
(Pearson Chi Square significance, 𝑝 = 0.000). There was no
statistical difference in the percentage of patients receiving
general anaesthesia or receiving blood transfusions. There
was no statistically significant difference in cumulative mor-
tality at 1, 3, 6, and 12 months, as well as till the latest follow-
up. The mean estimated survival was 43.1 months for both
AMA and cemented implants (resp., 95% CI: 39.6–46.6 and
39.0–47.3, log rank test 𝑝 = 0.621). Figure 1 shows patient
survival until latest follow up.
One out of three patients with cemented arthroplasty
who died within one month had a cause of death related
to respiratory failure. This patient had chronic obstructive
airway disease and died two days after surgery without an
autopsy. We observed no deaths within one month after
surgery in the matched group of patients who received the
AMA.
Including those with an earlier known mortality or
known complication, 79.7% (102) patients with cemented
hemiarthroplasty and 82% (105) patients were included
into analysis of complications. In these patients, 4.2% (5)
cemented and 18.9% (23) AMAs, respectively, had a surgical
complication (double sided Fisher’s exact test, 𝑝 = 0.000).
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Figure 1: Patient survival until latest follow-up. Log rank test 𝑝 =
0.621.
2.5% (3) cemented and 19.7% (24) AMAs (double sided
Fisher’s exact test, 𝑝 = 0.000) had definite radiological
evidence of implant loosening or subsidence of more than
5mm before one year. One and four patients, respectively,
had a posterior dislocation of the prosthesis. One and three
patients, respectively, had deep infection. The differences in
incidence of dislocation and infection were not statistically
significant (double sided Fisher’s exact test, 𝑝 = 0.369 and
𝑝 = 0.621, resp.).
One cemented hemiarthroplasty and seven AMAs had
an intraoperative crack (double sided Fisher’s exact test,
𝑝 = 0.056). Additionally, there were five cracks in the
cemented group as a result of an intended AMA insertion
which led to conversion to a cemented systemwithout further
consequence, and thesewere not counted as a complication in
either group. Cerclage wires were placed for all seven cracks
which occurred at AMA insertion and five of them still had
eventual implant loosening.
3.4% (4) of cemented hemiarthroplasties versus 6.6% (8)
of AMAs received one or more reoperations (double sided
Fisher’s exact test, 𝑝 = 0.238). In the cemented group,
this included one open reduction and internal fixation of
periprosthetic fracture, one conversion to a long stemmed
total hip arthroplasty for aseptic loosening, one debridement
procedure of deep infection, and one open reduction of an
incarcerated posterior dislocation with sciatic nerve palsy.
For the AMA group, there were three stem revisions for
aseptic loosening, two reentries for cerclage wiring of missed
intraoperative cracks, one multistaged revision for septic
loosening, one debridement procedure of deep infection,
and one Girdlestone procedure for aseptic loosening with
dislocation.
7.1% (8) of cemented hemiarthroplasties patients versus
24.8% (29) of AMAs experienced clinically significant thigh
pain or hip pain at any time point during the follow-up
period; this difference was statistically significant (double
sided Fisher’s exact test, 𝑝 = 0.000).
88.3% (113) of cemented hemiarthroplasty and 91.4% (117)
of AMAs had adequate clinical data to grade their maximum
walking status after rehabilitation. In terms of walking status,
there was no statistically significant difference between the
two groups.
In summary of the significant findings, compared to
patients with a cemented hemiarthroplasty, patients with an
AMA were 3.5 times more likely to have thigh pain (RR:
95% CI: 1.67–7.33), NNT = 5.6 (95% CI: 3.7–11.8), 4.47 (RR:
95% CI: 1.77–11.30) times more likely to have complications,
NNT = 5.9 (95% CI: 3.8–12.5), including 8.42 (RR: 95% CI:
2.63–26.95) times more likely to have implant loosening up
to latest follow-up, NNT = 4.6 (95% CI: 3.2–7.8), and 7.77
times (RR: 95% CI: 2.41–25.01), NNT = 5.0 (95% CI: 3.5–9.0),
more likely to have implant loosening within one year after
surgery. Moreover, patients with an AMA had an increased
but statistically insignificant trend in having more revisions,
intraoperative cracks, dislocations, and infections.
In our locality, the cost difference between a cemented
hemiarthroplasty and an AMA is around USD$400. Based
on the calculated NNT, cemented hemiarthroplasty would
potentially be cost saving if the following expenditures are
exceeded inmanaging each bad outcome: thigh pain (NNT =
5.6, USD$2240), any complications (NNT = 5.9, USD$2360),
and loosening (NNT = 4.6, USD$1840). However, since cost
analysis was not the main objective of the current study,
the above calculations can only be taken as approximate
estimations.
4. Discussion
In this study we were able to sufficiently prove that routine
usage of cemented stems resulted in improved outcome of
patients within one year after surgery. Our findings agreed
well with the two previous randomized studies [5, 10].
After a number of unmatched studies which suggested
inferiority of the AMA against cemented hemiarthroplasties
[3, 4, 8, 16], Sonne-Holm et al. [5] were the first to publish a
Randomized Clinical Trial (RCT) of 112 patients comparing
the uncemented AMA against the cemented AMA in 1982.
It was concluded that cementation of the same prostheses
resulted in significantly better pain relief and gait function.
Despite that, the practice of cementing an AMA was not
widely accepted because of its design intent and worries of
extreme difficulty in removal due to cement interlocking
with a perforated stem. Twenty years later, Parker et al.
performed another high quality RCT with 400 patients
comparing the cementedThompson against the uncemented
AMA.The cemented group had less pain and better mobility
[10]. These studies have heavily influenced a number of
followingmeta-analyses [17–19], where authors also conclude
that cementation improved pain and function. Our study is
the third such comparative study that used matched data of
AMAs versus cemented hemiarthroplasties.
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One patient who received a cemented prosthesis in our
study died from cardiopulmonary related complications two
days after surgery. However, since an autopsy was not carried
out, it was uncertain whether this may have been related
to cement thromboembolic events. The risk of cementation
remains to be important in patients prone to cardiopul-
monary and cerebrovascular compromise [9]. Our study
and the other RCTs are likely underpowered to reiterate the
small but significant (0.3% versus 0.04%, Pearson Chi square,
𝑝 = 0.02) risk of intraoperative deaths observed from 8639
cemented and 2477 uncemented hemiarthroplasties in the
Norwegian hip registry [8].
As shown by other studies, the cemented prosthesis
usually resulted in better walking function in addition to
thigh pain. This finding however was only reflected in our
results (Table 2) before PS matching and mitigated after
matching.We therefore believe that walking outcome is more
affected by the patient’s premorbid status. Patients with poor
cognitive status and limited rehabilitation potential may have
similar walking function regardless of the implant being used.
More patients had intraoperative cracks during implan-
tation of AMAs. Despite only having borderline statistical
significance in this study, it is noteworthy that five addi-
tional cracks that were not counted as complications in
the cemented group actually resulted from intended AMA
implantations. This is in agreement with other studies [8, 17,
20], showing that cementless hemiarthroplasties are associ-
ated with more iatrogenic fractures in osteoporotic patients.
It is uncertain here whether better leg length, offset, and
soft tissue tension restoration provided bymodular cemented
implants may have resulted in a small but insignificant trend
of less dislocations in cemented implants. It is also unknown
from our results whether routine use of gentamicin loaded
antibiotic cement may have led to a small but insignificant
trend of less infections in cemented hips.
It should be noted that older cementless monobloc stems
such as the AMA are distinct from modern cementless
modular porous coated prosthesis. The monobloc stems
have a number of notable shortcomings. Firstly, the AMA’s
nonmodular design does not allow for adjustment of the
femoral neck length and total hip conversions must be
performed with a stem exchange. Secondly, the AMA has
a matt and nonporous coated surface finish, providing less
surface friction and less early stability and no opportunity
for bone ingrowth when compared to porous coated stems.
Thirdly, the AMA has a concave medial and convex lateral
stem profile and comes in only two available sizes, providing
less reliable fitting and three-point stability when compared
to double or triple tapered modern stems that are made to
fit a variety of canals. These fundamental design differences
should be consideredwhen interpreting the conclusions from
a number of recent meta-analyses [17–19] which generally
compared cemented and cemented hemiarthroplasties and
were heavily influenced by the inferior outcomes of the older
cementless monobloc stems.
In a number of more recent studies, modern porous
coated cementless hemiarthroplasties had mixed outcomes
when compared against cemented implants. Rogmark et al.
[21] observed inferior cementless implant survival at five
years andmore periprosthetic fractures in patients older than
75 years but not younger patients in the Norway and Swedish
national registry. Langslet et al. [22] demonstrated in an RCT
thatwhilemodern porous coated cementless hemiarthroplas-
ties had a higher risk of periprosthetic fractures, patients had
better hip scores after 5 years. Two other RCTs by Talsnes
et al. [23] and Deangelis et al. [24] demonstrated similar
functional outcome and low complication rates for modern
modular cemented and cementless designs in the first year.
In all, not all of the newer studies agreed with each other
and the older studies with cementlessmonobloc stems. Better
powered studies and renewed meta-analysis are needed.
It is also possible that subgroups of patients may benefit
differently from specific modern cemented or uncemented
prosthesis.
There are a number of limitations in this study. Firstly,
this is a retrospective nonrandomized study.We attempted to
negate confounding by PSmatching. As thereweremany cog-
nitively impaired patients who were unable to give consent
for an RCT, this may be the next best way to do a comparison
study. PSmatching has been used in a large number of clinical
studies and is becoming increasingly popular [12, 25]. The
caliper nearest-neighbour matching technique is one of the
standard methods in obtaining optimal balance in moderate
to large samples [15]. The main drawbacks of propensity
score matching are the trade-off in statistical power and
systemic failure when some important confounding factors
are overlooked. In our study we eliminated 194 cases. The
findings may not apply to the frailest andmost active patients
as they may have been excluded during matching. This
also reduced this study’s statistical power in detecting less
remarkable differences.
Secondly, the group of cemented hemiarthroplasties
was not homogenous. It comprised patients with cemented
Thompsons, cemented AMAs, and cemented collarless pol-
ished tapered modular stems with monopolar or bipolar
heads. Nonetheless, we viewed them as a single group based
on the current literature which suggested minimal to no
difference between these cemented implants [26, 27]. Lastly,
the clinical outcome analysis in this study was partially
flawed because standardized scoring systems were not used
and 19% of patients either died or had insufficient clinical
documentation at follow-up.
5. Conclusion
Cemented hemiarthroplasties outperformed the AMAs in
terms of pain control, implant stability, and complication
rate. We detected no increased early mortality related to
cementing complications. We support the routine use of
cemented hemiarthroplasties for geriatric intracapsular hip
fractures.
Disclosure
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6 BioMed Research International
Ta
bl
e
2:
O
ut
co
m
es
co
m
pa
re
d
be
tw
ee
n
ce
m
en
te
d
ve
rs
us
A
M
A
gr
ou
ps
be
fo
re
an
d
aft
er
PS
m
at
ch
in
g.
O
ut
co
m
es
be
fo
re
an
d
aft
er
PS
m
at
ch
in
g
Be
fo
re
PS
m
at
ch
in
g
A
fte
rP
S
m
at
ch
in
g
Re
lat
iv
er
isk
(9
5%
CI
)
N
N
T
(9
5%
CI
)
C
em
en
te
d
A
M
A
𝑝
va
lu
e
C
em
en
te
d
A
M
A
𝑝
va
lu
e
14
6
ca
se
s
30
4
ca
se
s
12
8
ca
se
s
12
8
ca
se
s
M
ea
n
𝑛
or
(r
an
ge
,S
D
)
M
ea
n
𝑛
or
(r
an
ge
,S
D
)
M
ea
n
𝑛
or
(r
an
ge
,S
D
)
M
ea
n
𝑛
or
(r
an
ge
,S
D
)
D
ur
at
io
n
of
Su
rg
er
y
69
.1
m
in
s
(2
1–
17
1,
23
.6
)
53
.7
m
in
s
(2
0–
13
5,
21
.4
)
0.
00
0
67
.7
m
in
s
(2
1–
13
9,
22
.5
)
56
.1
m
in
s
(2
1–
13
5,
21
.6
)
0.
00
0
G
en
er
al
an
ae
st
he
sia
26
.7
%
36
17.
4%
53
0.
02
2
25
.8
%
33
18
.0
%
23
0.
13
1
Re
ce
iv
ed
bl
oo
d
tr
an
sfu
sio
n
35
.6
%
52
38
.2
%
11
6
0.
60
2
35
.9
%
46
32
.0
%
41
0.
51
0
D
ie
d
at
1m
on
th
2.
1%
3
3%
9
0.
57
7
2.
3%
3
0.
0%
0
0.
08
2
D
ie
d
at
3
m
on
th
s
4.
8%
7
7.9
%
24
0.
22
5
4.
7%
6
3.
1%
4
0.
52
1
D
ie
d
at
6
m
on
th
s
8.
2%
12
11
.8
%
36
0.
24
4
8.
6%
11
8.
6%
11
1.0
00
D
ie
d
at
12
m
on
th
s
12
.3
%
18
19
.1%
58
0.
07
4
12
.5
%
16
15
.6
%
20
0.
47
4
To
ta
ll
en
gt
h
of
sta
y
(m
ea
n,
SD
)
29
.3
da
ys
(2
–2
92
,2
6.
9)
29
.6
da
ys
(5
–1
30
,1
6.
8)
0.
88
0
29
.8
da
ys
(2
–2
92
,2
8.
4)
31
.8
da
ys
(1
2–
13
0,
18
.0
)
0.
50
8
Fu
lfi
ll
cli
ni
ca
l
an
al
ys
is
cr
ite
ria
88
.4
%
12
9
86
.5
%
26
3
0.
58
5
88
.3
%
11
3
91
.4
%
117
0.
41
0
po
st-
op
fu
nc
tio
na
l
w
al
ke
r
83
.7
%
10
8
74
.9
%
19
7
0.
05
3
81
.4
%
92
80
.3
%
94
0.
86
8
po
st-
op
re
cr
ea
tio
na
lw
al
ke
r
21
.7
%
28
5.
3%
14
0.
00
0
15
.9
%
18
9.4
%
11
0.
16
5
U
na
bl
et
o
m
ai
nt
ai
n
w
al
ki
ng
fu
nc
tio
n
42
.6
%
55
44
.9
%
11
8
0.
74
6
45
.1%
51
49
.6
%
58
0.
51
2
po
st-
op
th
ig
h
pa
in
6.
2%
8
22
.4
%
59
0.
00
0
7.1
%
8
24
.8
%
29
0.
00
0
3.
50
(1
.6
7–
7.3
3)
5.
6
(3
.7–
11
.8
)
Fu
lfi
ll
co
m
pl
ic
at
io
n
an
al
ys
is
cr
ite
ria
80
.1
117
81
.3
24
7
0.
77
9
79
.7
%
10
2
82
.0
%
10
5
0.
63
5
Cr
ac
ks
fro
m
at
te
m
pt
ed
A
M
A
4.
3%
5
4.
9%
5
C
om
pl
ic
at
io
ns
4.
3%
5
21
.9
%
54
0.
00
0
4.
9%
5
21
.9
%
23
0.
00
0
4.
47
(1
.7
7–
11
.3
0)
5.
9
(3
.8
–1
2.
5)
Lo
os
en
in
g
2.
6%
3
23
.1%
57
0.
00
0
2.
9%
3
24
.8
%
26
0.
00
0
8.
42
(2
.6
3–
26
.9
5)
4.
6
(3
.2
–7
.8
)
Lo
os
en
in
g
be
fo
re
1
ye
ar
2.
6%
3
21
.9
%
54
0.
00
0
2.
9%
3
22
.9
%
24
0.
00
0
7.7
7
(2
.4
1–
25
.0
1)
5.
0
(3
.5
–9
.0
)
Re
vi
sio
n
su
rg
er
ie
s
3.
4%
4
6.
9%
17
0.
23
3
3.
9%
4
7.6
%
8
0.
37
4
In
tr
ao
pe
ra
tiv
e
cr
ac
k
0.
9%
1
5.
3%
13
0.
04
3
1.0
%
1
6.
7%
7
0.
06
5
D
isl
oc
at
io
ns
0.
9%
1
3.
2%
8
0.
28
2
1.0
%
1
3.
8%
4
0.
36
9
In
fe
ct
io
ns
0.
9%
1
2.
8%
7
0.
44
5
1.0
%
1
2.
9%
3
0.
62
1
Tr
au
m
at
ic
pe
rip
ro
sth
et
ic
fr
ac
tu
re
s
0.
9%
1
1.2
%
3
1.0
00
1.0
%
1
0.
0%
0
0.
49
3
N
N
T:
nu
m
be
rn
ee
de
d
to
tre
at
.
D
ou
bl
es
id
ed
Fi
sh
er
’s
ex
ac
tt
es
tf
or
di
ch
ot
om
ou
sv
ar
ia
bl
es
.
Tw
o-
ta
ile
d
In
de
pe
nd
en
ts
am
pl
ed
𝑡
-te
st
fo
rc
on
tin
uo
us
va
ria
bl
es
.
BioMed Research International 7
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
Acknowledgments
The authors would like to acknowledge Ms. Kathine Ching,
Ms. Margaret Ho, Ms. Amanda Li, Ms. Elaine Tian for data
recovery and entry.
References
[1] A. T.Moore, “The self-lockingmetal hip prosthesis,”The Journal
of Bone & Joint Surgery—American Volume, vol. 39, no. 4, pp.
811–827, 1957.
[2] S. Graves, D. Davidson, R. DeSteiger et al., Australian
Orthopaedic Association National Joint Replacement Registry
Annual Report, Australian Orthopaedic Association National
Joint Replacement Registry, 2014.
[3] R. J. K. Khan, A. MacDowell, P. Crossman, and G. S. Keene,
“Cemented or uncemented hemiarthroplasty for displaced
intracapsular fractures of the hip—a systematic review,” Injury,
vol. 33, no. 1, pp. 13–17, 2002.
[4] J. D. Wrighton and J. E. Woodyard, “Prosthetic replacement for
subcapital fractures of the femur: a comparative survey,” Injury,
vol. 2, no. 4, pp. 287–293, 1971.
[5] S. Sonne-Holm, S. Walter, and J. S. Jensen, “Moore hemi-
arthroplasty with and without bone cement in femoral neck
fractures: a clinical controlled trial,” Acta Orthopaedica, vol. 53,
no. 6, pp. 953–956, 1982.
[6] C. Fang, K.-Y. Chiu, W.-M. Tang, and D. Fang, “Cementless
total hip arthroplasty specifically designed for Asians: clinical
and radiologic results at a mean of 10 years,” The Journal of
Arthroplasty, vol. 25, no. 6, pp. 873–879, 2010.
[7] P. L. Althausen, M. Lu, K. C. Thomas, S. F. Shannon, B.
N. Biagi, and E. M. Boyden, “Implant standardization for
hemiarthroplasty: implementation of a pricing matrix system
at a level II community based trauma system,” The Journal of
Arthroplasty, vol. 29, no. 4, pp. 781–785, 2014.
[8] J.-E. Gjertsen, S. A. Lie, T. Vinje et al., “More re-operations
after uncemented than cemented hemiarthroplasty used in
the treatment of displaced fractures of the femoral neck: an
observational study of 11,116 hemiarthroplasties from a national
register,” The Journal of Bone & Joint Surgery—British Volume,
vol. 94, no. 8, pp. 1113–1119, 2012.
[9] J. Christie, R. Burnett, H. R. Potts, and A. C. H. Pell,
“Echocardiography of transatrial embolism during cemented
and uncemented hemiarthroplasty of the hip,” The Journal of
Bone and Joint Surgery—British Volume, vol. 76, no. 3, pp. 409–
412, 1994.
[10] M. I. Parker, G. Pryor, and K. Gurusamy, “Cemented versus
uncemented hemiarthroplasty for intracapsular hip fractures: a
randomised controlled trial in 400 patients,”The Journal of Bone
& Joint Surgery—British Volume, vol. 92, no. 1, pp. 116–122, 2010.
[11] T.-W. Lau, C. Fang, and F. Leung, “The effectiveness of a
geriatric hip fracture clinical pathway in reducing hospital
and rehabilitation length of stay and improving short-term
mortality rates,”Geriatric Orthopaedic Surgery&Rehabilitation,
vol. 4, no. 1, pp. 3–9, 2013.
[12] M. Caliendo and S. Kopeinig, “Some practical guidance for
the implementation of propensity score matching,” Journal of
Economic Surveys, vol. 22, no. 1, pp. 31–72, 2008.
[13] T. W. Lau, C. Fang, and F. Leung, “Assessment of postoperative
short-term and long-term mortality risk in Chinese geriatric
patients for hip fracture using the Charlson comorbidity score,”
Hong Kong Medical Journal, vol. 22, no. 1, pp. 16–22, 2016.
[14] F. Thoemmes, “Propensityscore matching in SPSS,” http://arxiv
.org/abs/1201.6385.
[15] P. C. Austin, “A comparison of 12 algorithms for matching on
the propensity score,” Statistics in Medicine, vol. 33, no. 6, pp.
1057–1069, 2014.
[16] G. K. Singh and R. G. Deshmukh, “Uncemented Austin-
Moore and cementedThompson unipolar hemiarthroplasty for
displaced fracture neck of femur—comparison of complications
and patient satisfaction,” Injury, vol. 37, no. 2, pp. 169–174, 2006.
[17] M. J. Parker, K. S. Gurusamy, and S. Azegami, “Arthroplasties
(with and without bone cement) for proximal femoral fractures
in adults,” Cochrane Database of Systematic Reviews, no. 6,
Article ID CD001706, 2010.
[18] X. Luo, S. He, Z. Li, and D. Huang, “Systematic review
of cemented versus uncemented hemiarthroplasty for dis-
placed femoral neck fractures in older patients,” Archives of
Orthopaedic and Trauma Surgery, vol. 132, no. 4, pp. 455–463,
2012.
[19] T. Li, Q. Zhuang, X. Weng, L. Zhou, and Y. Bian, “Cemented
versus uncemented hemiarthroplasty for femoral neck fractures
in elderly patients: a meta-analysis,” PLoS ONE, vol. 8, no. 7,
Article ID e68903, 2013.
[20] D. Davidson, J. Pike, D. Garbuz, C. P. Duncan, and B. A.
Masri, “Intraoperative periprosthetic fractures during total hip
arthroplasty: evaluation and management,”The Journal of Bone
& Joint Surgery—American Volume, vol. 90, no. 9, pp. 2000–
2012, 2008.
[21] C. Rogmark, A. M. Fenstad, O. Leonardsson et al., “Posterior
approach and uncemented stems increases the risk of reoper-
ation after hemiarthroplasties in elderly hip fracture patients,”
Acta Orthopaedica, vol. 85, no. 1, pp. 18–25, 2014.
[22] E. Langslet, F. Frihagen, V. Opland, J. E.Madsen, L. Nordsletten,
and W. Figved, “Cemented versus uncemented hemiarthro-
plasty for displaced femoral neck fractures: 5-year followup of a
randomized trial,” Clinical Orthopaedics and Related Research,
vol. 472, no. 4, pp. 1291–1299, 2014.
[23] O. Talsnes, F. Hjelmstedt, A. H. Pripp, O. Reikera˚s, and O.
E. Dahl, “No difference in mortality between cemented and
uncemented hemiprosthesis for elderly patients with cervical
hip fracture. A prospective randomized study on 334 patients
over 75 years,”Archives of Orthopaedic and Trauma Surgery, vol.
133, no. 6, pp. 805–809, 2013.
[24] J. P. Deangelis, A. Ademi, I. Staff, and C. G. Lewis, “Cemented
versus uncemented hemiarthroplasty for displaced femoral
neck fractures: a prospective randomized trial with early follow-
up,” Journal of Orthopaedic Trauma, vol. 26, no. 3, pp. 135–140,
2012.
[25] F. J. Thoemmes and E. S. Kim, “A systematic review of
propensity score methods in the social sciences,” Multivariate
Behavioral Research, vol. 46, no. 1, pp. 90–118, 2011.
[26] A. Enocson, C. J. Hedbeck, H. To¨rnkvist, J. Tidermark, and L. J.
Lapidus, “Unipolar versus bipolar Exeter hip hemiarthroplasty:
a prospective cohort study on 830 consecutive hips in patients
with femoral neck fractures,” International Orthopaedics, vol.
36, no. 4, pp. 711–717, 2012.
[27] T. Bhattacharyya and K. J. Koval, “Unipolar versus bipolar
hemiarthroplasty for femoral neck fractures: is there a differ-
ence?” Journal of Orthopaedic Trauma, vol. 23, no. 6, pp. 426–
427, 2009.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
